Elevation of Urinary Liver-Type Fatty Acid-Binding Protein Is a Harbinger of Poor Patient Prognosis after Allogeneic Stem Cell Transplantation

被引:0
作者
Shingai, Naoki [1 ]
Ota, Akihito [2 ]
Kato, Kana [1 ]
Kondo, Kaori [1 ]
Sadaga, Yasutaka [1 ]
Kato, Chika [1 ]
Sakai, Satoshi [1 ]
Kambara, Yasuhiro [1 ]
Nabe, Yoshimi [1 ]
Asano, Kazuya [1 ]
Teshima, Koh [1 ]
Kurihara, Kazuya [1 ]
Ouchi, Fumihiko [1 ]
Fujiwara, Hiroki [1 ]
Shimabukuro, Masashi [1 ]
Inai, Kazuki [1 ]
Jinguji, Atsushi [1 ]
Toya, Takashi [1 ]
Shimizu, Hiroaki [1 ]
Najima, Yuho [1 ]
Kobayashi, Takeshi [1 ]
Sugaya, Takeshi [3 ]
Ando, Minoru [4 ]
Doki, Noriko [1 ]
机构
[1] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Hematol Div, 3-18-22 Honkomagome,Bunkyo Ku, Tokyo 1138677, Japan
[2] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Nephrol, Bunkyo Ku, Tokyo, Japan
[3] St Marianna Univ, Dept Internal Med, Div Nephrol & Hypertens, Sch Med, Kawasaki, Kanagawa, Japan
[4] Jiseikai Mem Hosp, Dept Med, Itabashi Ku, Tokyo, Japan
来源
TRANSPLANTATION AND CELLULAR THERAPY | 2024年 / 30卷 / 01期
关键词
uL-FABP; Biomarker; Kidney injury; RISK;
D O I
10.1016/j.jtct.2023.10.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several recent studies have demonstrated that urinary levels of liver-type fatty acid-binding protein (L-FABP) can be used to stratify the prognosis of cardiac disease, cardiac intensive care unit admission, cirrhosis, and coronavirus disease 2019. Our initial prospective study revealed that urinary L-FABP (uL-FABP) was associated with a high probability of acute kidney injury after stem cell transplantation (SCT); however, the relevance of elevated uL-FABP to the prognosis of patients undergoing SCT remains to be determined. We aimed to investigate whether uL-FABP levels can be used to stratify patient prognosis after SCT. To achieve this aim, we conducted a new long-term follow-up study using data from patients enrolled in our preceding prospective cohort study. Patients were classified into high and low uL-FABP groups based on levels measured at baseline (ie, before initiating the conditioning regimen), using an uL-FABP cutoff of 8.4 mu g/gCr, which was determined based on data from healthy adults. uL-FABP levels were also measured on days 0, 7, and 14 after SCT. Cox proportional hazard regression was used to examine the effects of each factor on survival outcomes, and Fine-Gray regression was used in the presence of competing risks. Multivariate analysis incorporating confounders was then performed for factors with P < .1 in univariate analysis. In total, 20 of 84 patients (23.8%), 57 of 84 patients (67.9%), 34 of 49 patients (69.4%), and 34 of 46 patients (73.9%) were classified into the high uL-FABP group at baseline and on days 0, 7, and 14, respectively. The 5-year overall survival (OS) rate was 23.9% in the high uL-FABP group and 68.9% in the low uL-FABP group. The multivariate analysis identified a high uL-FABP level at baseline as a significant prognostic factor for poor OS (hazard ratio [HR], 3.54; P = .002). The 5-year cumulative incidence rate for nonrelapse mortality (NRM) was 50.0% in the high uL-FABP group and 19.9% in the low uL-FABP group. In the multivariate analysis, high uL-FABP at baseline was a significant prognostic factor for NRM (HR, 3.37; P = .01). uL-FABP levels did not significantly stratify the cumulative incidence of relapse (HR, 2.13; P = .11). uL-FABP levels on days 0, 7, and 14 were not significant predictors of survival. High uL-FABP level before initiation of conditioning significantly influences OS and NRM following SCT, whereas a high uL-FABP level at any point after the conditioning regimen does not. Our results show that measuring uL-FABP level at baseline may be a simple way to predict survival in patients undergoing SCT. (c) 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:121e1 / 121e8
页数:8
相关论文
共 19 条
[1]   Acute Kidney Injury in the Modern Era of Allogeneic Hematopoietic Stem Cell Transplantation [J].
Abramson, Matthew H. ;
Gutgarts, Victoria ;
Zheng, Junting ;
Maloy, Molly A. ;
Ruiz, Josel D. ;
Scordo, Michael ;
Jaimes, Edgar A. ;
Sathick, Insara Jaffer .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (09) :1318-1327
[2]   COVID-19-induced acute renal tubular injury associated with elevation of serum inflammatory cytokine [J].
Fukao, Yusuke ;
Nagasawa, Hajime ;
Nihei, Yoshihito ;
Hiki, Makoto ;
Naito, Toshio ;
Kihara, Masao ;
Gohda, Tomohito ;
Ueda, Seiji ;
Suzuki, Yusuke .
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (11) :1240-1246
[3]   Impact of severe acute kidney injury and chronic kidney disease on allogeneic hematopoietic cell transplant recipients: a retrospective single center analysis [J].
Gutierrez-Garcia, Gonzalo ;
Villarreal, Jesus ;
Garrote, Marta ;
Rovira, Montserrat ;
Blasco, Miquel ;
Suarez-Lledo, Maria ;
Gerardo Rodriguez-Lobato, Luis ;
Charry, Paola ;
Rosinol, Laura ;
Marin, Pedro ;
Pedraza, Alexandra ;
Teresa Solano, Maria ;
Ramos, Carla ;
de Llobet, Noemi ;
Lozano, Miquel ;
Cid, Joan ;
Martinez, Carmen ;
Poch, Esteban ;
Carreras, Enric ;
Urbano-Ispizua, Alvaro ;
Fernandez-Aviles, Francesc ;
Pereira, A. ;
Quintana, Luis F. .
BONE MARROW TRANSPLANTATION, 2020, 55 (07) :1264-1271
[4]   Renal Complications of Hematopoietic-Cell Transplantation [J].
Hingorani, Sangeeta .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (23) :2256-2267
[5]   Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis [J].
Juanola, Adria ;
Graupera, Isabel ;
Elia, Chiara ;
Piano, Salvatore ;
Sole, Cristina ;
Carol, Marta ;
Perez-Guasch, Martina ;
Bassegoda, Octavi ;
Escude, Laia ;
Rubio, Ana-Belen ;
Cervera, Marta ;
Napoleone, Laura ;
Avitabile, Emma ;
Ma, Ann T. ;
Fabrellas, Nuria ;
Pose, Elisa ;
Morales-Ruiz, Manuel ;
Jimenez, Wladimiro ;
Torres, Ferran ;
Crespo, Gonzalo ;
Sola, Elsa ;
Gines, Pere .
JOURNAL OF HEPATOLOGY, 2022, 76 (01) :107-114
[6]   Clinical Significance of Urinary Liver-Type Fatty Acid-Binding Protein in Diabetic Nephropathy of Type 2 Diabetic Patients [J].
Kamijo-Ikemori, Atsuko ;
Sugaya, Takeshi ;
Yasuda, Takashi ;
Kawata, Takehiro ;
Ota, Akio ;
Tatsunami, Shinobu ;
Kaise, Ruriko ;
Ishimitsu, Toshihiko ;
Tanaka, Yasushi ;
Kimura, Kenjiro .
DIABETES CARE, 2011, 34 (03) :691-696
[7]   Urinary L-Type Fatty Acid-Binding Protein Predicts Oxygen Demand of COVID-19 in Initially Mild Cases [J].
Katagiri, Daisuke ;
Asai, Yusuke ;
Ohmagari, Norio ;
Ishikane, Masahiro ;
Hikida, Sayaka ;
Iwamoto, Noriko ;
Nagashima, Maki ;
Suzuki, Minami ;
Takano, Hideki ;
Takasaki, Jin ;
Hojo, Masayuki ;
Sugiyama, Haruhito ;
Tokunaga, Katsushi ;
Miyashita, Yoshihiro ;
Omata, Masao ;
Ohata, Keiichi ;
Bliden, Kevin P. ;
Tantry, Udaya S. ;
Dahlen, Jeffrey R. ;
Sugaya, Takeshi ;
Gurbel, Paul A. ;
Noiri, Eisei .
CRITICAL CARE EXPLORATIONS, 2023, 5 (03) :E0873
[8]   Acute kidney injury within 100 days post allogeneic hematopoietic cell transplantation is associated with increased risk of post-transplant complications and poor transplant outcomes [J].
Madsen, Kayla ;
Pelletier, Karyne ;
Cote, Gabrielle ;
Kitchlu, Abhijat ;
Chen, Shiyi ;
Mattsson, Jonas ;
Pasic, Ivan .
BONE MARROW TRANSPLANTATION, 2022, 57 (09) :1411-1420
[9]   Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts [J].
McDonald, George B. ;
Sandmaier, Brenda M. ;
Mielcarek, Marco ;
Sorror, Mohamed ;
Pergam, Steven A. ;
Cheng, Guang-Shing ;
Hingorani, Sangeeta ;
Boeckh, Michael ;
Flowers, Mary D. ;
Lee, Stephanie J. ;
Appelbaum, Frederick R. ;
Storb, Rainer ;
Martin, Paul J. ;
Deeg, H. Joachim ;
Schoch, Gary ;
Gooley, Ted A. .
ANNALS OF INTERNAL MEDICINE, 2020, 172 (04) :229-+
[10]   Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury [J].
Mehta, Ravindra L. ;
Kellum, John A. ;
Shah, Sudhir V. ;
Molitoris, Bruce A. ;
Ronco, Claudio ;
Warnock, David G. ;
Levin, Adeera .
CRITICAL CARE, 2007, 11 (02)